WebMD explains the use of monoclonal antibodies to treat advanced colorectal cancer, including side effects.
"During cancer treatment a person needs to focus on their health. It is not a time for a patient to worry about how they are going to pay for the drugs. This is simply unacceptable."Jack Shapiro, Chair of the Canadian Cancer Action Network says that Canadians need universal, equitable ...
"There are some biochemical differences between the drugs," he noted. On the other hand, all three have been shown to roughly double the time patients remain progression-free, Tripathy said. Norton pointed to another, related question: Once a woman on Kisqali sees her cancer progress, c...
Neurotoxicity caused by traditional chemotherapy and radiotherapy is widely recognized in patients with cancer. The adverse effects of newer therapeutics, such as biological and immunotherapeutic agents, are less well established, and are associated with considerable neurotoxicity in the central and peripheral...
In addition to its earlier FDA approval for prevention of cervical cancer, Gardasil has received FDA approval for use in preventing vaginal and vulvar cancers in girls and women age 9 to 26. Kansas City pharmacists mobilize to fight meth use By: Tirusha Dave ...
Home > Section > Chapter Aneja, S.; Newton, R.W. Indian Journal of Pediatrics 63(2): 233-241 1996 ISSN/ISBN:0019-5456 10829995 10.2165/00002018-199411010-00005 009095962 Full-Text Article emailed within 0-6 h Buy Now for$19.90
Single-agent rituximab as first-line and maintenance treatment for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma: a phase II trial of the Minnie Pearl Cancer Research Network J Clin Oncol, 21 (2003), pp. 1746-1751 View in ScopusGoogle Scholar 21 S.M. O'Brien, H....
Although, using more drugs earlier in the course may be where the practice and state-of-the-art for treatment intervention moves really over the next year or two, quite frankly, as we look at changes that have already occurred in current guidelines....
Drugs Aging. 2017;34(11):859–68. Article PubMed PubMed Central Google Scholar Cottone M, et al. Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. Clin Gastroenterol Hepatol. 2011;...
Sequential and concomitant therapy with four drugs is equally effective for eradication of H. pylori infection. Clin Gastroenterol Hepatol. 2010;8(1):36–41. 16. Greenberg ER, Anderson GL, Morgan DR, et al. 14-day triple, 5-day concomitant, and 10-day sequential therapies for ...